Abstract
Acetylcholine (ACh) biosensor is developed based on mediator-free acetylcholine oxidase (AChOx) by selfassembled monolayer (SAM) onto lab-made micro-chip. The simple cyclic voltammetry (CV) method is utilized in mediator- free system in phosphate buffer solution (PBS, 0.1M) at room conditions. The analytical parameters of AChOx fabricated electrode employed a lower detection limit (DL, 0.136 nM), a wide linear dynamic range (LDR, 1.0 nM to 1.0 mM), good linearity (R= 0.9991), and higher sensitivity (2.7329 μAmM-1cm-2) where a tiny sample volume (70.0 μL) is required. The micro-chip system executes a simple and efficient approach to immobilize the enzymes onto SAM modified surface, which can improve the biosensor performances for a large group of biomolecules in broad scale of biomedical applications in health-care fields.
Keywords: Acetylcholine oxidase, acetylcholine, cyclic voltammetry, detection limit, immobilization, linear dynamic range, mediator-free system, micro-chips, phosphate buffer solution, selectivity, self-assembled monolayer, sensitivity, stability, thioglycolic acid
Current Proteomics
Title:Development of Mediator-Free Acetylcholine Biosensor Based on Acetylcholine Oxidase Immobilized Micro-Chips
Volume: 9 Issue: 4
Author(s): Mohammed Muzibur Rahman
Affiliation:
Keywords: Acetylcholine oxidase, acetylcholine, cyclic voltammetry, detection limit, immobilization, linear dynamic range, mediator-free system, micro-chips, phosphate buffer solution, selectivity, self-assembled monolayer, sensitivity, stability, thioglycolic acid
Abstract: Acetylcholine (ACh) biosensor is developed based on mediator-free acetylcholine oxidase (AChOx) by selfassembled monolayer (SAM) onto lab-made micro-chip. The simple cyclic voltammetry (CV) method is utilized in mediator- free system in phosphate buffer solution (PBS, 0.1M) at room conditions. The analytical parameters of AChOx fabricated electrode employed a lower detection limit (DL, 0.136 nM), a wide linear dynamic range (LDR, 1.0 nM to 1.0 mM), good linearity (R= 0.9991), and higher sensitivity (2.7329 μAmM-1cm-2) where a tiny sample volume (70.0 μL) is required. The micro-chip system executes a simple and efficient approach to immobilize the enzymes onto SAM modified surface, which can improve the biosensor performances for a large group of biomolecules in broad scale of biomedical applications in health-care fields.
Export Options
About this article
Cite this article as:
Muzibur Rahman Mohammed, Development of Mediator-Free Acetylcholine Biosensor Based on Acetylcholine Oxidase Immobilized Micro-Chips, Current Proteomics 2012; 9 (4) . https://dx.doi.org/10.2174/157016412805219143
DOI https://dx.doi.org/10.2174/157016412805219143 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Defective HIF Signaling Pathway and Brain Response to Hypoxia in Neurodegenerative Diseases: Not an “Iffy” Question!
Current Pharmaceutical Design Neuropathic Pain: Models and Mechanisms
Current Pharmaceutical Design GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design Effects of Nicotine During Pregnancy: Human and Experimental Evidence
Current Neuropharmacology Heterocycles in the Treatment of Neglected Tropical Diseases
Current Medicinal Chemistry NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimers Disease
Current Pharmaceutical Design Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets Progress of In Vivo Electroporation in the Rodent Brain
Current Gene Therapy Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research Castration Resistant Prostate Cancer (CRPC): State of the Art, Perspectives and New Challenges
Anti-Cancer Agents in Medicinal Chemistry Functions of MAPR (Membrane-Associated Progesterone Receptor) Family Members As Heme/Steroid-Binding Proteins
Current Protein & Peptide Science Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Functional Genomics: New Insights into the Function of Low Levels of Gene Expression in Stem Cells
Current Genomics Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
CNS & Neurological Disorders - Drug Targets Polycation-Based Gene Therapy: Current Knowledge and New Perspectives
Current Gene Therapy Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Migraine and Central Sensitization: Clinical Features, Main Comorbidities and Therapeutic Perspectives
Current Rheumatology Reviews Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
Current Drug Targets Targeted Blood-to-Brain Drug Delivery – 10 Key Development Criteria
Current Pharmaceutical Biotechnology Nicotinamide and its Pharmacological Properties for Clinical Therapy
Drug Design Reviews - Online (Discontinued)